US Stock MarketDetailed Quotes

XENE Xenon Pharmaceuticals

Watchlist
  • 42.630
  • -0.520-1.21%
Close Nov 29 13:00 ET
  • 42.630
  • 0.0000.00%
Post 16:01 ET
3.25BMarket Cap-15170P/E (TTM)

Xenon Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Xenon Pharmaceuticals Q3 2024 Earnings Date

Currency：USDNov 12, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
0
0
0
--
--
--
EPS
-0.81
-0.81
+<0.01
Beat Est.
-11.17%
-10.96%
+0.17%
Analyst Rating
Strong Buy

Nov 14, 2024

Xenon Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 294.120K--
Nov 12, 20242024/Q30.000 / 0.000--
Aug 8, 20242024/Q20.000 / 0.000--
May 9, 20242024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 294.120K--
Nov 12, 20242024/Q30.000 / 0.000--
Aug 8, 20242024/Q20.000 / 0.000--
May 9, 20242024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Xenon Pharmaceuticals Earnings Reports

  • Xenon Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 12 16:41 ET

  • Xenon Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 8 16:42 ET

  • Xenon Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

    May 9 16:39 ET

  • Xenon Pharmaceuticals | 8-K: Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update

    May 9 16:18 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 14, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data